Fundraising FoxLife Biosciences
Boston, US · Founded 2017 · Delaware LLC · 7 known investors
Find your way into Life Biosciences
Sign up to see every warm intro you have to Life Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Life Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Life Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.
Founders & leadership
Life Biosciences was founded in 2017 by David Sinclair.
DS
David SinclairFounder · Board Member, Investor, AdvisorA Harvard Medical School professor of genetics with a Ph.D. from UNSW and postdoctoral training at MIT, Sinclair has published over 200 papers on aging biology and holds more than 50 patents; he is director of Life Biosciences, a longevity company developing therapies to extend healthy human lifespan.
MR
Michael RingelChief Operating OfficerMichael Ringel holds a B.A. in biology from Princeton University, a Ph.D. in biology from Imperial College, and a J.D. from Harvard Law School. He spent over 25 years at BCG as a Managing Director and Senior Partner before joining Life Biosciences as Chief Operating Officer.
AS
Amit ShashankChief Administrative Officer + General CounselAmit Shashank is an Executive Officer at Life Biosciences, a longevity company developing therapies to extend healthy human lifespan. He brings over two decades of experience in technology and biotech, with prior roles including general counsel at a public company, and expertise in M&A, corporate finance, and venture capital transactions.
AT
Alexander Tristan EdwardsExecutive
MK
Mehmood KhanExecutiveMehmood Khan previously held senior leadership positions including Chief Scientific Officer of Global R&D at PepsiCo and President of Global R&D at Takeda Pharmaceuticals, with earlier clinical expertise as Director of the Diabetes, Endocrine and Nutritional Trials Unit at Mayo Clinic and a fellowship in clinical endocrinology and nutrition from the University of Minnesota. He is now Chief Executive Officer of Life Biosciences, a longevity company developing therapies to extend healthy human lifespan.
BM
Brian MaloneExecutive
Board
IS
Ilan SternBoard director
SG
Stuart GibsonBoard director
DG
David GuyerBoard director
BD
Bracken DarrellBoard director
Investors · 7
Alpha Wave Globallisted by Alpha Wave GlobalMiami
How we know: Alpha Wave Global's portfolio page · Not right? Tell us
__Twitter.png)
The Venture Collectivelisted by The Venture CollectiveMiami Beach · $100K – $500K
How we know: The Venture Collective's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$154.4M disclosed across 3 of 4 rounds · 2018–2025
▶$31MraisedApr 2026 · 8 investors · OtherRule 506(b)
▶$31MraisedApr 2026 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Stuart GibsonDirector
- Gerald McLaughlinExecutive Officer, Director
- David GuyerDirector
- David SinclairDirector
- Sharon Rosenzweig-LipsonExecutive Officer
- Michael RingelExecutive Officer
- Amit ShashankExecutive Officer
- Ilan SternDirector
- Offering amount
- $31M
- Amount sold
- $31M
- Finders' fees
- $30K
- Placement agents
- Chatsworth Securities LLC
- First sale
- Nov 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$74.8MraisedJun 2021 · 35 investors · OtherRule 506(b)
▶$74.8MraisedJun 2021 · 35 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ilan SternDirector
- Bracken DarrellDirector
- Mehmood KhanExecutive Officer, Director
- Alexander Tristan EdwardsPromoter
- Brian MaloneExecutive Officer
- David SinclairDirector, Promoter
- Stuart GibsonDirector
- Amit ShashankExecutive Officer
- Offering amount
- $100M
- Amount sold
- $74.8M
- Finders' fees
- $321.7K
- Placement agents
- McKenny McFarlane Capital Ltd, Morgan Stanley Australia Securities Limited
- First sale
- May 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶Undisclosed amountofferedSep 2020 · 6 investors · OtherRule 506(b)
▶Undisclosed amountofferedSep 2020 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Bracken DarrellDirector
- David SinclairDirector
- Ilan SternDirector
- Stuart GibsonDirector
- Alexander Tristan EdwardsExecutive Officer
- Mehmood KhanExecutive Officer
- Amit ShashankExecutive Officer
- Brian MaloneExecutive Officer
- First sale
- Sep 2020
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$48.6MraisedJan 2019 · 45 investors · OtherRule 506(c)
▶$48.6MraisedJan 2019 · 45 investors · Other
Rule 506(c)Officers, directors & promoters on the filing
- Bracken DarrellDirector
- Adam NeumannDirector
- David SinclairDirector, Promoter
- Alexander Tristan EdwardsExecutive Officer, Promoter
- Brian MaloneExecutive Officer
- Stuart GibsonDirector
- Offering amount
- $50.9M
- Amount sold
- $48.6M
- Finders' fees
- $1.5M
- Placement agents
- Morgan Stanley Australia Securities Limited, Race Rock Capital LLC
- First sale
- Aug 2018
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Pano AIPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.
Companies working in the same space as Life Biosciences.
In the news
Frequently asked questions
- What does Life Biosciences do?
- Life Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.
- Who founded Life Biosciences?
- Life Biosciences was founded by David Sinclair in 2017.
- Who are Life Biosciences's investors?
- Life Biosciences's investors include Alpha Wave Global, Gaingels, PHD Ventures, The Venture Collective, W ventures, W Ventures, Life Biosciences.
- How much funding has Life Biosciences raised?
- Life Biosciences has disclosed $154.4M raised across 3 of its 4 known rounds.
- Where is Life Biosciences headquartered?
- Life Biosciences is headquartered in Boston, US.